8-K filed August 21, 2024, 7:59 PM ET ticker LFCR CIK 0001005286

other material confidence high sentiment neutral materiality 0.60

Lifecore shareholders approve board declassification, share increase; appoints four new directors

LIFECORE BIOMEDICAL, INC. DE

Shareholders approved phased-in board declassification: 21.6M for, 77K against.
Authorized common shares increased to 75M from 50M.
Four new directors appointed: Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, Matthew Korenberg.
Director Nathaniel Calloway resigned post-meeting; no disagreement cited.
2019 Stock Incentive Plan amended: +300K shares available, total 3,059,797 shares.

item 3.03 item 5.02 item 5.03 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Humberto C. Antunes

Director

LFCR · LIFECORE BIOMEDICAL, INC. DE

Effective: 2024-08-15
Filed: August 21, 2024, 7:59 PM ET

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

Appointed

Paul H. Johnson

Director

LFCR · LIFECORE BIOMEDICAL, INC. DE

Effective: 2024-08-15
Filed: August 21, 2024, 7:59 PM ET

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

Appointed

Matthew Korenberg

Director

LFCR · LIFECORE BIOMEDICAL, INC. DE

Effective: 2024-08-15
Filed: August 21, 2024, 7:59 PM ET

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

Appointed

Jason Aryeh

Director

LFCR · LIFECORE BIOMEDICAL, INC. DE

Effective: 2024-08-15
Filed: August 21, 2024, 7:59 PM ET

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Humberto C. Antunes was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul H. Johnson was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Korenberg was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Aryeh was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors

View on SEC.gov

LIFECORE BIOMEDICAL, INC. DE filing history →

Source: SEC EDGAR

accession 0001005286-24-000119

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.